To evaluate the efficacy and safety of KW-3357 with concomitant use of heparin using
multi-center, non-comparative, open-label method in patients diagnosed as disseminated
intravascular coagulation (DIC) by the diagnostic criteria for DIC established by the
Japanese Ministry of Health and Welfare.
Phase:
Phase 3
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited Kyowa Kirin Co., Ltd.